Overview
John Eppensteiner, MD is an Assistant Professor in the Department of Emergency Medicine. He completed his emergency medicine training here at Duke University during which time he served as chief resident. He also completed the first-of-its-kind integrated research fellowship year which is now an established pathway in the Duke Emergency Medicine Residency Program. His research interests are primarily focused on the immune response to trauma and early inflammatory biomarkers used in predictive modeling after traumatic injury. Dr. Eppensteiner has also served as site PI for several clinical trials enrolling patients in the Emergency Department.
Current Appointments & Affiliations
Assistant Professor of Emergency Medicine
·
2023 - Present
Emergency Medicine,
Clinical Science Departments
Recent Publications
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Journal Article JAMA Netw Open · August 1, 2022 IMPORTANCE: The monoclonal antibody combination of casirivimab and imdevimab reduced viral load, hospitalization, or death when administered as a 1200-mg or greater intravenous (IV) dose in a phase 3 COVID-19 outpatient study. Subcutaneous (SC) and/or lowe ... Full text Link to item CiteOrganization of Outpatient Care After COVID-19 Hospitalization.
Journal Article Chest · June 2022 Full text Open Access Link to item CiteUtility of COVID-19 antigen testing in the emergency department.
Journal Article J Am Coll Emerg Physicians Open · February 2022 BACKGROUND: The BinaxNOW coronavirus disease 2019 (COVID-19) Ag Card test (Abbott Diagnostics Scarborough, Inc.) is a lateral flow immunochromatographic point-of-care test for the qualitative detection of severe acute respiratory syndrome coronavirus 2 (SA ... Full text Open Access Link to item CiteRecent Grants
Elucidating and mitigating the effects of Damage Associated Molecular Patterns (DAMPs) released following severe traumatic injury.
ResearchCo Investigator · Awarded by Department of Defense · 2024 - 2026Surgical Critical Care Initiative (SC2I): Civilian application of military decision support tools for critically injured patients.
ResearchCo Investigator · Awarded by Henry M. Jackson Foundation · 2021 - 2026A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19
Clinical TrialPrincipal Investigator · Awarded by Regeneron Pharmaceuticals, Inc. · 2020 - 2026View All Grants
Education, Training & Certifications
Wright State University, Boonshoft School of Medicine ·
2015
M.D.
Saint Louis University ·
2011
B.A.